Advanced search
Publication Cover
Expert Review of Molecular Diagnostics Volume 4, 2004 - Issue 1
Submit an article Journal homepage
66
Views
21
CrossRef citations to date
0
Altmetric
Review

Prenatal screening for cystic fibrosis: past, present and future

Carolyn S Richards Department of Molecular and Medical Genetics, DNA Diagnostic Laboratory, Oregon Health Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA. [email protected]
&
Wayne W Grody Medical Genetics/Molecular Pathology, UCLA School of Medicine, 10833 Conte Avenue, Los Angeles, CA 90095-1732, USA. [email protected]
Pages 49-62 | Published online: 09 Jan 2014

References

  • Riordan JR, Rommens JM, Kerem B etal Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245, 1066–1073 (1989).
  • •Announced the identification and characterization of the causative gene for cystic fibrosis KR
  • Kerem B, Rommens JM, Buchanan JA et al Identification of the cystic fibrosis gene: genetic analysis. Science 245, 1073–1080 (1989).
  • Farrell PM, Post N. Prenatal screening for cystic fibrosis: where are we now?' Perliatr 141,758–768 (2002)
  • Richards CS, Haddow J. Prenatal screening for cystic fibrosis. In: Clinics in Laboratmy Medicine. Schmidt RA (Ed.), WB Saunders Co., PA, USA (2003) (In Press).
  • Zielenski J, Tsui LC. Cystic fibrosis: genotypic and phenotypic variations. Ann. Rev Genet. 29,777–807 (1995).
  • Abeliovich D, Lavon IP, Lerer I eta]. Screening for five mutations detects 97% of cystic fibrosis (CF) chromosomes and predicts a carrier frequency of 1:29 in the Jewish Ashkenazi population. Am. j Hum. Genet. 51,951-956 (1992).
  • Cystic Fibrosis Genotype-Phenotype Consortium. Correlation between genotype and phenotype in patients with cystic fibrosis. N Engl. Med 329,1308–1313 (1993).
  • Burke W Aitken ML, Chen SH, Scott CR. Variable severity of pulmonary disease in adults with identical cystic fibrosis mutations. Chest 102,506–509 (1992).
  • Grody WW. Cystic fibrosis: molecular diagnosis, population screening and public policy. Arch. Athol Lab. Med 123, 1041–1046 (1999).
  • Grody WW, Desnick RJ. Cystic fibrosis population carrier screening: here at last: are we ready? Genet. Med 3,87-90 (2001). iiNIH Consensus Development Conference Statement. Genetic testing for cystic fibrosis. April 14–16,1997. Atrh. Intern. Med 159,1529–1539 (1999).
  • Mennuti MT, Thomson E, Press N. Screening for cystic fibrosis carrier state. Obstet. Gynecol 93,456–461 (1999).
  • Grody WW, Cutting GR, Klinger KW et al Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genet. Med 3,149–154 (2001).
  • •Contains the detailed professional recommendations from the American College of Medical Genetics for CF carrier screening in the USA, including the 25-mutation core panel and model test report forms.
  • Bobadilla JL, Farrell MET, Farrell PM. Applying CFTR molecular genetics to facilitate the diagnosis of cystic fibrosis through screening. Adv. Pecliatr 49, 131–190 (2002).
  • Richards CS, Bradley LA, Amos J eta]. Standards and guidelines for CFI R mutation testing. Genet. Med 4,379–391 (2002).
  • Strom CM, Huang D, Chen C eta]. Extensive sequencing of the cystic fibrosis transmembrane regulator gene: assay validation and unexpected benefits of developing a comprehensive test. Genet. Med 5,9–14 (2003).
  • DeMarchi JM, Richards CS, Fenwick RG, Pace R, Beaudet AL. A robotics-assisted procedure for large-scale cystic fibrosis mutation analysis. Hum. Mutat. 4, 281–290 (1994).
  • DeMarchi JM, Caskey CT, Richards CS. Population-specific screening by mutation analysis for diseases frequent in Ashkenazi Jews. Hum. Mutat. 8,116–125 (1996).
  • Shuber AP, Skoletsky J, Stem R, Handelin BL. Efficient 12-mutation testing in the CFTR gene: a general model for complex mutation analysis. Hum. MM. Genet. 2,153-158 (1993).
  • Shuber AP, Michalowsky LA, Nass GS etal High-throughput parallel analysis of hundreds of patient samples for more than 100 mutations in multiple disease genes. Hum. MM. Genet. 6,337-347 (1997).
  • Cai SP, Wall J, Kan YVV, Chehab FE Reverse dot blot probes for the screening of beta-thalassemia mutations in Asians and American blacks. Hum. Mutat. 3,59–63 (1994).
  • Chehab FF, Wall J. Detection of multiple cystic fibrosis mutations by reverse dot blot hybridization: a technology for carrier screening. Hum. Genet. 89,163–168 (1992).
  • •Early demonstration of the practicality of multiplex hybridization of numerous cystic fibrosis transmembrane conductance regulator gene mutation probes bound to a solid support, establishing the basis for later mass-produced commercial test systems.
  • Wall J, Cai S, Chehab FE A 31-mutation assay for cystic fibrosis testing in the clinical molecular diagnostics laboratory. Hum. Mutat. 5,333-338 (1995).
  • Watson MS, Desnick RJ, Grody WW etal Cystic fibrosis carrier screening: issues in implementation. Genet. Med. 4,407–409 (2002).
  • •Discussion of some of the early problems which have surfaced in the CF carrier screening program, particularly in reporting of the 5T polymorphism and clinical significance of the 1148T mutation.
  • Ferrie RM, Schwarz MJ, Robertson NH et al Development, multiplexing and application of ARMS tests for common mutations in the CFTR gene. 4in.j Hum. Genet. 51, 251–262 (1992).
  • Gilfillan A, Axton R, Brock DJ. Mass screening for cystic fibrosis heterozygotes: two assay systems compared. Clin. Chem. 40, 197–199 (1994).
  • Miedzybrodzka ZH, Yin Z, Kelly KF, Haites NE. Evaluation of laboratory methods for cystic fibrosis carrier screening: reliability, sensitivity, specificity and costs." Med Genet 31, 545–550 (1994).
  • Goldblatt J, Creegan R, Edkins T etal Mutation analysis of Western Australian families affected by cystic fibrosis. Med. J. Aust. 162, 12–15 (1995).
  • Robertson NH, Weston SL, Kelly SJ etal Development and validation of a screening test for 12 common mutations of the cystic fibrosis CFTR gene. Eur Respir.1. 12, 477–482 (1998).
  • Bradley LA, Johnson DA, Chaparro CA, Robertson NH, Ferrie RM. A multiplex ARMS test for 10 cystic fibrosis (CF) mutations: evaluation in a prenatal CF screening program. Genet. Test. 2, 337–341 (1998).
  • Feldmann D, Guittard C, Georges MD etal Genetic testing for cystic fibrosis: evaluation of the Elucigene CF20 kit in blood and buccal cells. Ann. Biol. Gun. 59, 277–283 (2001).
  • Brinson EC, Adriano T, Bloch W etal Introduction to PCR/OLA/SCS, a multiplex DNA test and its application to cystic fibrosis. Genet. Test. 1, 61–68 (1997).
  • Jurinke C, van den Boom D, Cantor CR, Koster H. The use of MassARRAY technology for high-throughput genotyping. Adv Biochem. Eng. Biotechnol 77, 57–74 (2002).
  • Kaetzke A, Eschrich K. Simultaneous determination of different DNA sequences by mass spectrometric evaluation of Sanger sequencing reactions. Nucleic Acids Res. 30, E117 (2002).
  • Bonk T, Humeny A, Gebert J etal Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry-based detection of microsatellite instabilities in coding DNA sequences: a novel approach to identify DNA-mismatch repair-deficient cancer cells. Gun. Chem. 49, 552–561 (2003).
  • Hegde MR, Richards CS. Assay development and validation for mutations common in the Ashkenazi Jewish population. Genet. Med (2003) (Abstract 150)
  • Clinical Laboratory Improvement Amendments. Federal Register. CLIA 1988, Volume 65, No 87, 25928–25934 (2000).
  • NCCLS. Molecular Diagnostic Methods for Genetic Diseases: Approved Guideline. NCCLS document MM1-A. National Committee for Clinical Laboratory Standards, PA, USA, 395–397 (2000).
  • Palomaki GE, Bradley AL, Richards CS, Haddow JE. Analytic validity of cystic fibrosis testing: a preliminary estimate. Genet. Med 5, 15–20 (2003).
  • Palomaki GE, Haddow JE, Bradley LA, FitzSimmons SC. Updated assessment of cystic fibrosis mutation frequencies in non-Hispanic Caucasians. Genet. Med 4, 90–94 (2002).
  • Heim RA, Sugarman EA, Allitto BA. Improved detection of cystic fibrosis mutations in the heterogeneous US population using an expanded, pan-ethnic mutation panel. Genet. Med 3, 168–176 (2001).
  • Witt DR, Schaefer C, Hallam P etal Cystic fibrosis heterozygote screening in 5,161 pregnant women. Am J. Hum. Genet. 58, 823–835 (1996).
  • Wald NJ. Couple screening for cystic fibrosis. Lancet338, 1318–1319 (1991).
  • •Model for simultaneous couple screening and reporting intended to avoid some of the difficulties in counseling positive-negative couples; it remains somewhat controversial, especially in the USA.
  • Super M, Schwarz MJ, Malone G etal Active cascade testing for carriers of cystic fibrosis gene. BE Med 308, 1462–1467 (1994).
  • Cystic Fibrosis Foundation. Patient Registry Annual Data Report, 1998. Cystic Fibrosis Foundation, MD, USA (1998).
  • Rohlfs EM, Zhou Z, Sugarman EA et al The I148T CFTR allele occurs on multiple haplotypes: a complex allele is associated with cystic fibrosis. Genet. Med 4, 319–323 (2002).
  • •First report of the complex nature of the 1148T mutation, part of the core 25-mutation screening panel, which is apparently not expressed unless coupled with the 3199de16 variant in the same allele.
  • Strom CM, Huang D, Buller A eta]. Cystic fibrosis screening using the College panel: platform comparison and lessons learned from the first 20,000 samples Genet. Med 4, 289–296 (2002).
  • Grody WW, Dunkel-Schetter C, Tatsugawa ZH etal PCR-based screening for cystic fibrosis carrier mutations in an ethnically diverse pregnant population. AIR Hum. Genet. 60, 935–947 (1997).
  • Grody WW, Desnick RJ, Carpenter NJ, Noll WW. Diversity of cystic fibrosis mutation-screening practices. Am. J. Hum. Genet. 62, 1252–1254 (1998).
  • •This survey of CF testing laboratories participating in a nationwide proficiency testing program revealed wide variability in mutation test panels and highlighted the need for professional guidelines.
  • Dequeker E, Ramsden S, Grody WW, Stenzel TT, Barton DE. Quality control in molecular genetic testing. Nature Rev Genet. 2, 717–723 (2001).
  • Stenzel TT, Bernacki SH, Beck JC etal Establishment of stably transformed cell lines from residual clinical blood samples for use in performance evaluation and quality assurance in molecular genetic testing. Am. J. Hum. Genet. 69(Suppl.), 438 (2001).
  • Jarvis MR, Williams LO, Grody WW. Cystic fibrosis as a model system for construction of mutation samples for human molecular genetic testing. Genet. Med 4, 210 (2002).
  • Witt DR, Coppinger J. Cystic fibrosis prenatal screening of 27,000 women in a large HMO. Am.j Hum. Genet. 69(Suppl.), 176 (2001)
  • American College of Obstetricians and Gynecologists and American College of Medical Genetics. Preconception and prenatal carrier sarening for cystic fibrosis: clinical and laboratory guidelines. American College of Obstetricians and Gynecologists, WA, USA (2001). Websites

Websites

  • Population-based prenatal screening for cystic fibrosis via carrier testing. A CDC sponsored project (2002) www.fbr.org (Viewed December 2003)
  • Cystic Fibrosis Mutation Database www.genet.sickkids.on.ca/cftr (Viewed December 2003)
  • American College of Medical Genetics. Standards and Guidelines for Clinical Genetics Laboratories (2003) www.acmg.net (Viewed December 2003)
  • College of American Pathologists. Molecular Pathology Checklist www.cap.org (Viewed December 2003)
  • New York State Department of Health. Clinical Laboratory Evaluation Program: Genetic Testing www.wadsworth.orgilabcert(Viewed December 2003)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.